LISA SULLIVAN to Hypertension
This is a "connection" page, showing publications LISA SULLIVAN has written about Hypertension.
Connection Strength
0.510
-
Circulating Adipokines and Vascular Function: Cross-Sectional Associations in a Community-Based Cohort. Hypertension. 2016 Feb; 67(2):294-300.
Score: 0.068
-
Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment. J Am Heart Assoc. 2015 Nov 20; 4(11).
Score: 0.068
-
Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension. 2012 Dec; 60(6):1393-9.
Score: 0.055
-
Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease. Am Heart J. 2010 Oct; 160(4):715-20.
Score: 0.048
-
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009 Feb 28; 373(9665):739-45.
Score: 0.043
-
Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring. Hypertension. 2007 Mar; 49(3):439-45.
Score: 0.037
-
Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005 Jan; 45(1):28-33.
Score: 0.032
-
Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study. Hypertension. 2003 Dec; 42(6):1100-5.
Score: 0.030
-
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003 Feb; 27(2):260-8.
Score: 0.028
-
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002 Sep 09; 162(16):1867-72.
Score: 0.027
-
Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010 Nov 22; 170(21):1909-17.
Score: 0.012
-
Aortic root remodeling over the adult life course: longitudinal data from the Framingham Heart Study. Circulation. 2010 Aug 31; 122(9):884-90.
Score: 0.012
-
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007 Jul 31; 116(5):480-8.
Score: 0.010
-
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005 Dec 01; 80(1):45-53.
Score: 0.008
-
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005 Dec 01; 80(1):19-32.
Score: 0.008
-
Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 2005 Mar 15; 142(6):393-402.
Score: 0.008
-
The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004 Mar; 27(3):704-8.
Score: 0.008
-
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003 Mar 25; 107(11):1486-91.
Score: 0.007